Interim CEO & Director of Biomea Fusion Michael J. Hitchcock Buys 667% More Shares

Whilst it may not be a huge deal, we thought it was good to see that the Biomea Fusion, Inc. (NASDAQ:BMEA) Interim CEO & Director, Michael J. Hitchcock, recently bought US$99k worth of stock, for US$0.99 per share. While that isn't the hugest buy, it actually boosted their shareholding by 667%, which is good to see.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

The Last 12 Months Of Insider Transactions At Biomea Fusion

Notably, that recent purchase by Michael J. Hitchcock is the biggest insider purchase of Biomea Fusion shares that we've seen in the last year. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$1.54. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

Biomea Fusion insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for Biomea Fusion

Biomea Fusion is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Insider Ownership Of Biomea Fusion

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 6.8% of Biomea Fusion shares, worth about US$6.5m, according to our data. We do generally prefer see higher levels of insider ownership.

So What Do The Biomea Fusion Insider Transactions Indicate?

It is good to see recent purchasing. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. On this analysis the only slight negative we see is the fairly low (overall) insider ownership; their transactions suggest that they are quite positive on Biomea Fusion stock. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Biomea Fusion. For instance, we've identified 6 warning signs for Biomea Fusion (3 are significant) you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.